Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides

about

Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides

Item

http://www.wikidata.org/entity/Q28552026

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@ast

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@en

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@nl

type

Item

label

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@ast

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@en

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@nl

prefLabel

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@ast

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@en

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@nl

P1476

Novel Promising Estrogenic Rec ...... nilides and Dithiobenzanilides

@en

P2093

Hanna Piotrowska

http://www.w3.org/2001/XMLSchema#string

Malgorzata Kucinska

http://www.w3.org/2001/XMLSchema#string

Natalia Lisiak

http://www.w3.org/2001/XMLSchema#string

Thomas Erker

http://www.w3.org/2001/XMLSchema#string

Walter H Granig

http://www.w3.org/2001/XMLSchema#string

P2860

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

SwissDock, a protein-small molecule docking web service based on EADock DSS

Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

UCSF Chimera--a visualization system for exploratory research and analysis

Selective estrogen receptor modulators (SERMs): a review of clinical data.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).

Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations

Selectively targeting estrogen receptors for cancer treatment.

P304

e0145615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0145615

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289489244

http://www.w3.org/2001/XMLSchema#string

P698

26730945

http://www.w3.org/2001/XMLSchema#string

P932

4701221

http://www.w3.org/2001/XMLSchema#string